UBS O'Connor’s Atlas Crest Investment Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50 ACII.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-102,752
Closed -$82K 766
2021
Q4
$82K Buy
102,752
+2,756
+3% +$2.49K ﹤0.01% 868
2021
Q3
$85K Hold
99,996
﹤0.01% 846
2021
Q2
$116K Hold
99,996
﹤0.01% 806
2021
Q1
$85K Buy
+99,996
New +$101K ﹤0.01% 770

Other funds holding ACII.WS

UBS O'Connor's ACII.WS Position: Q1 2022 in Review

UBS O'Connor sold out of Atlas Crest Investment Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50 (ACII.WS) in Q1 2022, closing a stake of 102,752 shares — an estimated $82K sold.

UBS O'Connor first reported a position in ACII.WS in Q1 2021 and held it in 4 quarters. The position peaked at $116K in Q2 2021. 55 funds tracked by Wall St. Rank hold ACII.WS as of Q1 2022.

  • UBS O'Connor reported no remaining Atlas Crest Investment Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50 position as of Q1 2022 after selling out during the quarter.
  • UBS O'Connor sold 102,752 Atlas Crest Investment Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50 shares in Q1 2022, an estimated $82K.
  • UBS O'Connor first reported a position in Atlas Crest Investment Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50 in Q1 2021 and held it in 4 quarters.
  • UBS O'Connor's Atlas Crest Investment Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50 position peaked at $116K in Q2 2021.
  • 55 funds tracked by Wall St. Rank held Atlas Crest Investment Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50 as of Q1 2022.

Based on UBS O'Connor's 13F filing for Q1 2022, filed 16 May 2022.